Concepedia

Author

Jean-Pierre Delord

Inserm

Also Known As

Jean-Pierre Delord

7

Publications

3.9K

Citations

4

H-Index

9

Concepts

All Affiliations

InsermInstitut Claudius Regaud
JD

About

Jean-Pierre Delord is an author at Inserm specializing in cancer therapeutics, radiation oncology, and oncology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

2

2

1.1K

2

Pharmacology

2

2

1.1K

3

Cancer Therapeutics

2

2

1.1K

4

Pathology

1

1

1.1K

5

Molecular Oncology

1

1

1.1K

Jean-Pierre Delord

×

3

Publications

3.9K

Citations

3

H-Index

YearCitations

Efficacy of Pembrolizumab in Patients With Noncolorectal High Microsatellite Instability/Mismatch Repair–Deficient Cancer: Results From the Phase II KEYNOTE-158 Study

Aurélien Marabelle, Dung T. Le, Paolo A. Ascierto,

Journal of Clinical Oncology

2019

2.8K

Molecularly targeted therapy based on tumour molecular profiling versus conventional therapy for advanced cancer (SHIVA): a multicentre, open-label, proof-of-concept, randomised, controlled phase 2 trial

Christophe Le Tourneau, Jean-Pierre Delord, Anthony Gonçalvès,

The Lancet Oncology

2015

1.1K

Selective Oral MEK1/2 Inhibitor Pimasertib in Metastatic Melanoma: Antitumor Activity in a Phase I, Dose-Escalation Trial

Célèste Lebbé, Antoîne Italiano, Nadine Houédé,

Targeted Oncology

2020

14

Page 1